Shenzhen Majory Biotechnology Co., Ltd.

This study tests a new drug called MR001 combined with standard chemotherapy for people with advanced pancreatic cancer that has worsened after initial treatment. The goal is to find a safe dose and see if the combination can shrink tumors or slow the disease. About 45 adults wit…

This study tests a new drug called MR001 in people with advanced triple-negative breast cancer (TNBC) whose cancer has worsened after standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. About 42 participants wil…